Search "Saxenda savings card" and you'll find dozens of pages confidently telling you to print a $25 copay card and walk into any pharmacy. Try it, and the pharmacist will tell you something different: that card hasn't existed for new patients since 2023.
This isn't a small formatting error. It's a gap between what Novo Nordisk actually offers today and what a lot of outdated or auto-generated content still claims. We went directly to NovoCare.com — the manufacturer's own cost and coverage site — to confirm the current status before writing a word of this guide.
Below is what's actually true in August 2026: why the Saxenda card disappeared, what Novo Nordisk offers instead, what brand and generic liraglutide cost right now, and the specific, still-active ways to bring your cost down.
What Happened to the Saxenda Savings Card
The Saxenda Savings Offer let commercially insured patients pay as little as $25 for a 30-day supply, similar to copay cards for many other brand-name drugs. Novo Nordisk closed the program to new enrollees on June 30, 2023. Patients who had already activated and redeemed a card by that date could keep using its benefit through December 31, 2023, but no new activations have been accepted since.
| Milestone | Date |
|---|---|
| Saxenda Savings Offer closed to new enrollees | June 30, 2023 |
| Final date to use benefits on cards activated before the cutoff | December 31, 2023 |
| Teva launches first FDA-approved generic liraglutide for weight loss | August 28, 2025 |
| Hikma and Meitheal launch competing generic liraglutide products | Early–mid 2026 |
| Current status of Saxenda Savings Card (as of this update) | Still discontinued — no relaunch announced |
Why the confusion persists: Many articles about Saxenda savings were written or last updated before mid-2023 and simply never got corrected. Others appear to be generated from older source material without checking Novo Nordisk's site directly. If a page cites a "$25 Saxenda copay card" without a 2023 discontinuation notice, treat that page's pricing information with caution.
On its official Saxenda cost and coverage page, Novo Nordisk now tells patients who need financial help: "the makers of Saxenda have another weight-management option with a savings offer" — a direct reference to Wegovy, which does have an active manufacturer savings program. That's a meaningful signal about where Novo Nordisk's commercial priorities sit in 2026, but it doesn't help you if your prescriber has you on Saxenda specifically and switching isn't the right clinical move for you.
Saxenda Cost in 2026: Brand vs. Generic
Without a manufacturer card, your out-of-pocket cost depends heavily on whether you're filling brand-name Saxenda or generic liraglutide, and whether you use a discount coupon.
| Product | List / Wholesale Price | Typical Cash Price | With GoodRx/SingleCare Coupon |
|---|---|---|---|
| Brand Saxenda, 5 pens (3.0mg maintenance dose) | ~$1,349 | $1,350–$1,650 | $1,220–$1,450 |
| Generic liraglutide (Teva, Hikma, Meitheal) | ~$1,165 | $1,000–$1,300 | $225–$400 |
| Generic liraglutide, smaller pen quantity (2–3 pens) | Varies by dose | $400–$700 | $100–$335 |
Ask specifically for generic liraglutide. Because the generic launched relatively recently, some pharmacy systems still default to filling brand Saxenda unless you or your prescriber specify the generic. That single question can be the difference of several hundred dollars a month.
Does Insurance Cover Saxenda?
Coverage for anti-obesity medications is inconsistent across insurers, and it's one of the more frequently changing categories of drug coverage in 2026. Some commercial plans cover Saxenda or generic liraglutide with prior authorization; others exclude anti-obesity medications from the formulary entirely, regardless of medical necessity.
| Scenario | What Usually Happens |
|---|---|
| Plan covers anti-obesity medications, PA approved | Copay, often $25–$100 depending on tier |
| Plan covers anti-obesity medications, no PA on file | Full cash price until PA is submitted and approved |
| Plan excludes anti-obesity medications from formulary | Full cash price regardless of documentation |
| Before annual deductible is met | Full negotiated (not list) price counts toward deductible |
Before assuming your plan won't cover Saxenda, call the number on your insurance card and ask directly whether anti-obesity medications are covered, and what documentation triggers prior authorization. See our Prior Authorization Guides for how that process typically works.
Coverage Comparison: Commercial vs. Medicare vs. Medicaid
| Coverage Type | Typical Coverage | Common Requirement |
|---|---|---|
| Commercial insurance | Plan-dependent; many require PA | Documentation of a weight-related medical condition |
| Medicare Part D | Generally excluded | Federal law bars coverage of weight-loss-only medications; check your Part D plan's formulary for exceptions |
| Medicaid | Varies significantly by state | A growing number of states now cover GLP-1s for weight management, but many still don't |
| Uninsured / cash-pay | Full price unless using a coupon | Discount card, PAP, or state assistance program needed |
Medicare coverage rules for anti-obesity medications have been the subject of ongoing legislative proposals. Confirm the current status with your specific Part D plan or on Medicare.gov rather than assuming last year's rules still apply.
GLP-1 Weight-Loss Medication Savings Card Comparison
If you're comparing Saxenda against other GLP-1 weight-loss medications specifically because of savings card availability, here's how the manufacturer programs currently stack up. Switching medications is always a clinical decision to make with your prescriber, not a savings tactic to pursue on your own.
| Medication | Manufacturer | Active Savings Card? |
|---|---|---|
| Saxenda (liraglutide) | Novo Nordisk | No — discontinued June 2023 |
| Generic liraglutide | Teva / Hikma / Meitheal | No manufacturer card; pharmacy discount coupons only |
| Wegovy (semaglutide) | Novo Nordisk | Yes, for eligible commercially insured patients |
| Zepbound (tirzepatide) | Eli Lilly | Yes, through Lilly's savings program for eligible patients |
This table reflects savings card availability only, not clinical suitability. Manufacturer programs change terms and eligibility frequently — always confirm current details on the official product site, such as NovoCare or Eli Lilly's own resources, before assuming a card applies to you.
Real Ways to Save on Saxenda Right Now
- Ask about generic liraglutide. With a discount coupon, it's frequently the single biggest cost reduction available for this medication class right now.
- Use a free discount card. GoodRx, SingleCare, and Optum Perks coupon prices for generic liraglutide are often far below both the brand cash price and the generic's own list price.
- Compare pharmacies. Cash and coupon prices for the same drug and dose can vary by hundreds of dollars between pharmacies in the same city — run a check on our Drug Price Checker before you fill.
- Confirm your plan's prior authorization requirements. A missing PA is one of the most common reasons an insured patient still gets charged full price.
- Check whether Saxenda is currently on Novo Nordisk's Patient Assistance Program list if you're uninsured or on Medicare and income-eligible.
- Ask your prescriber about a documented clinical need for the brand if generic isn't appropriate for your situation, since that documentation can support a formulary exception.
- Look into state pharmaceutical assistance programs through NeedyMeds or BenefitsCheckUp, since eligibility and coverage rules vary by state.
Patient Assistance: Is Saxenda Covered?
Novo Nordisk operates a Patient Assistance Program (PAP) that provides certain medications at no cost to eligible uninsured patients and Medicare beneficiaries who meet income requirements. The PAP is not specific to Saxenda — it's a broader program covering a defined list of Novo Nordisk medications that the company updates periodically.
Important: Whether Saxenda is currently on that covered medication list is not something we can guarantee will hold true by the time you read this. Some patients and clinics report that Novo Nordisk's PAP has, in certain periods, focused primarily on diabetes medications like Ozempic, Victoza, and insulin products rather than obesity medications. Confirm Saxenda's current status directly at NovoCare.com or by calling the Saxenda Hotline before you invest time in an application.
| General PAP Requirement | What It Means |
|---|---|
| Insurance status | Must have Medicare or no insurance — patients with private/commercial insurance are not eligible for the PAP |
| Income | Household income generally at or below 400% of the federal poverty level for most covered medications |
| Other government programs | Must not be enrolled in or qualify for Medicaid or Medicare Extra Help (LIS) — if eligible for either, a denial letter is required |
| Residency | U.S. residency with a prescription from a licensed provider |
Medicare patients: If your household income is below 150% of the federal poverty level, you're generally expected to apply for Extra Help (LIS) first. A denial letter from that program can then support your PAP application.
Income Limit Comparison for Patient Assistance
Federal poverty level (FPL) percentages are the standard yardstick manufacturers use to set patient assistance income limits. Use this table as a general planning guide, and confirm your exact figure with the program when you apply, since guidelines update annually.
| Household Size | ~400% FPL (approx. annual income) |
|---|---|
| 1 person | ~$62,600 |
| 2 people | ~$84,700 |
| 3 people | ~$106,800 |
| 4 people | ~$129,000 |
Federal poverty guidelines update annually, and exact thresholds can vary by manufacturer and by medication. Treat this table as a planning estimate, not a guarantee of eligibility — confirm your household's exact figure directly with the program.
How to Apply: Step by Step
Confirm Saxenda is currently on the PAP medication list
Call the Saxenda Hotline or check NovoCare.com before completing paperwork, since covered medications change.
Confirm you meet the insurance and income criteria
You'll need Medicare or no insurance, plus household income within the program's published limit for your household size.
Request the application
Download it from Novo Nordisk's patient assistance materials, or have your prescriber's office request it directly.
Complete the patient sections
Provide your information, household size, income, and insurance status, and sign where required.
Have your prescriber complete their section
Your provider confirms the diagnosis, medication, and dose, and signs the clinical portion of the application.
Attach proof of income and insurance status
A recent tax return or pay stubs, plus documentation of your insurance situation or a Medicaid/LIS denial letter if applicable.
Submit and follow up
Your prescriber's office typically submits on your behalf. Follow up after two weeks if you haven't heard back.
Approval Timelines and Renewal
| Stage | Typical Timeframe |
|---|---|
| Complete first-time application | 2–4 weeks |
| Application missing documents | Additional 2–3 weeks after resubmission |
| Renewal application | 1–3 weeks |
| Typical enrollment period | 12 months, then reapplication required |
Start your renewal a few weeks before your current enrollment expires. Updated income documentation is required even if your income hasn't changed, and a dose or medication switch generally requires a new application rather than a simple renewal.
Decision Tree: What's Your Cheapest Option?
Do you have insurance?
This determines which savings tools realistically apply to you
Ask about PA and generic liraglutide
Check formulary status and submit prior authorization
Plan excludes coverage?
Compare your copay against a coupon price for generic liraglutide
Use a GoodRx/SingleCare coupon
Generic liraglutide, roughly $225–$400/month
Income-eligible?
Check if Saxenda is currently on Novo Nordisk's PAP list
Still too expensive?
Ask your prescriber about clinically appropriate lower-cost alternatives
Pros and Cons of Switching to Generic Liraglutide
Pros
- Often several hundred dollars cheaper than brand with a discount coupon
- FDA-approved as therapeutically equivalent to brand Saxenda
- Multiple manufacturers (Teva, Hikma, Meitheal) now compete, which can pressure prices lower over time
- No manufacturer card required — just a standard pharmacy discount coupon
Cons
- No manufacturer savings card exists for the generic, unlike some brand GLP-1 competitors
- Some patients report differences adjusting to a different pen device — discuss with your prescriber
- Generic supply can be affected by the same liraglutide shortage issues as the brand
- Insurance may still require prior authorization even for the generic on some plans
Common Mistakes That Cost You Money
- Assuming the $25 Saxenda savings card is still active and being surprised at the pharmacy counter.
- Filling brand Saxenda without asking the pharmacist whether generic liraglutide is available and appropriate.
- Not checking whether your insurance requires prior authorization before your first fill attempt.
- Trying to use a manufacturer copay card with Medicare or Medicaid, which federal anti-kickback rules generally prohibit.
- Applying for Novo Nordisk's PAP without first confirming Saxenda is on the current covered medication list.
- Not comparing prices across nearby pharmacies before filling — coupon prices can vary significantly by location.
Most overpayment on Saxenda in 2026 comes down to outdated assumptions — either about the discontinued savings card, or about which product (brand vs. generic) is being filled by default. Asking two direct questions at the counter solves most of it: "Is the generic available, and what's my price with a discount card?"
Real Examples: What People Actually Pay
Example 1 — Uninsured, switched to generic with a coupon: A patient paying roughly $1,400/month cash for brand Saxenda asks their prescriber about generic liraglutide, then uses a SingleCare coupon at a different pharmacy. New price: around $310/month — a savings of over $13,000 a year.
Example 2 — Commercial insurance, prior authorization approved: A patient's prescriber documents a weight-related medical condition and submits a prior authorization request. Once approved, the plan places generic liraglutide on a covered tier, dropping the copay from full cash price to a fixed monthly amount.
Example 3 — Uninsured, checked PAP eligibility first: A patient with no insurance and income under the published threshold calls the Saxenda Hotline before applying to the PAP, confirms Saxenda is currently covered, and submits the application with their prescriber's help. After roughly three weeks, they're approved and receive medication at no cost.
Bottom Line
The Saxenda Savings Card isn't a current option — it hasn't been since June 2023 — and the sooner you stop planning around it, the sooner you can focus on what actually works. For most patients in 2026, that means asking about generic liraglutide, running a discount coupon before assuming a cash price, and checking your specific insurance plan's prior authorization rules.
If you're uninsured and income-eligible, confirm Saxenda's current status on Novo Nordisk's Patient Assistance Program before applying, since covered medications can change. And if cost keeps you from starting or continuing treatment altogether, that's a conversation worth having with your prescriber — not just a pricing problem to solve alone.